Does the cytokine adsorber CytoSorb(®) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study

BACKGROUND: Hemadsorption of cytokines is used in critically ill patients with sepsis or septic shock. Concerns have been raised that the cytokine adsorber CytoSorb(®) unintentionally adsorbs vancomycin. This study aimed to quantify vancomycin elimination by CytoSorb(®). METHODS: Critically ill pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Scharf, Christina, Weinelt, Ferdinand, Schroeder, Ines, Paal, Michael, Weigand, Michael, Zoller, Michael, Irlbeck, Michael, Kloft, Charlotte, Briegel, Josef, Liebchen, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124739/
https://www.ncbi.nlm.nih.gov/pubmed/35599248
http://dx.doi.org/10.1186/s13613-022-01017-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124739/
https://www.ncbi.nlm.nih.gov/pubmed/35599248
http://dx.doi.org/10.1186/s13613-022-01017-5

Ejemplares similares